Search clinical trials for: Delayed leg training

Total 15467 results

Johannes Gutenberg University Mainz

Unknown

Telmisartan, Amlodipine and Flow Mediated Dilation (TEAMSTAprotect)

Hypertension

Germany
Helse Fonna
University of Bergen; Helse Vest; Moodnet

Completed

Virtual Darkness as Additive Treatment in Mania (VATMAN)

Bipolar Disorder | Mania

Norway
University of Miami
Alkermes, Inc.

Recruiting

C-Cog in Early Course Schizophrenia Study

Schizophrenia

United States
Selda Sarıkaya
Zonguldak Bulent Ecevit University

Completed

The Aerobic Exercise Capacity and Muscle Strenght in Individuals With COVID-19

COVID-19 | COVID-19 Pneumonia

Turkey
Veru Inc.

Withdrawn

Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Oslo University Hospital
University Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaborators

Active, not recruiting

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer

Chemotherapy Effect | Locally Advanced Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic Adenocarcinoma | Pancreatectomy

Norway
Oncolytics Biotech
Montefiore Medical Center

Completed

Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer

KRAS Mutant Metastatic Colorectal Cancer

United States
West German Study Group
Sanofi; Roche Pharma AG

Terminated

Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)

Breast Cancer

Germany
Shahid Beheshti University of Medical Sciences

Completed

Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema

Diabetic Macular Edema

Iran, Islamic Republic of
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
GERCOR - Multidisciplinary Oncology Cooperative...
Merrimack Pharmaceuticals

Completed

A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer (DOUBLIRI)

Unresectable Advanced Cancer

France
Monash University
Schering-Plough

Withdrawn

Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study (ACCESS)

Hypertension

Australia
National Cancer Institute (NCI)

Completed

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Fallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer

United States
AstraZeneca

Completed

Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) (HORIZON I)

Colorectal Cancer

Czech Republic, France, Italy, Spain, United Kingdom, Germany, Canada, Austria, Belgium
Northwest Kansas Surgery Center

Completed

Preoperative Cataract Pupillary Dilation: Inpatient At The Ambulatory Surgery Center vs Outpatient Dilation Prior To Arrival At The Ambulatory Surgery Center

Pupil Dilation Prior to Cataract Surgery In-patient | Pupil Dilation Prior to Cataract Surgery Out-patient
Institute of Child Health

Completed

Vitamins and Minerals for Children With Downs Syndrome

Trisiomy 21 (Down Syndrome)

United Kingdom
Anabio R&D
Thai Binh University of Medicine and Pharmacy

Recruiting

LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media

Upper Respiratory Tract Infections

Vietnam
NCIC Clinical Trials Group

Completed

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Breast Cancer

Canada
NCIC Clinical Trials Group

Completed

Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme

Brain and Central Nervous System Tumors

Canada
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Breast Cancer

United States
Mayo Clinic

Completed

Non-intrusive Detection of Temporary Neurologic Impairment By Opioids

Healthy

United States
Greg Otterson
Celgene Corporation; National Comprehensive Cancer Network

Completed

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Lung Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Head and Neck Cancer

United States
LifeBridge Health
AstraZeneca

Unknown

Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor (HEIGHTEN)

Coronary Artery Disease

United States
Yonsei University

Unknown

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Lung Cancer

Korea, Republic of
Hasselt University
Universitaire Ziekenhuizen KU Leuven; Ziekenhuis Oost-Limburg

Completed

Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure (DIURESIS-CHF)

Heart Failure

Belgium
AbbVie (prior sponsor, Abbott)

Completed

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact (DAPHNE)

Advanced Idiopathic Parkinson's Disease
Thomas Olencki
Schering-Plough

Terminated

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Kidney Cancer

United States
St. Jude Children's Research Hospital
Assisi Foundation; Cookies for Kids' Cancer

Completed

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood B-Lymphoblastic Lymphoma

United States
NeuroWave Systems Inc.
Fraser Health; U.S. Army Medical Research Acquisition Activity

Completed

Effectiveness of the NeuroSENSE for Monitoring the Hypnotic Depth of Anesthesia

Depth of Anesthesia (DOA)

Canada
Sichuan University

Unknown

GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma

Lymphoma, Extranodal NK-T-Cell

China
LEO Pharma

Completed

LEO 90100 in the Treatment of Psoriasis Vulgaris

Psoriasis Vulgaris

United States
Ain Shams Maternity Hospital

Completed

Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine

Pain, Postoperative

Egypt
Gilead Sciences

Completed

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

Hepatitis C | HIV

Puerto Rico
Assaf-Harofeh Medical Center

Unknown

Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance (TEG)

Acute ST SEgment Elevation Myocardial Infarction

Israel
Amgen

Completed

A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer

Breast Cancer

United States
City of Hope Medical Center

Completed

Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Patras

Completed

Effect of Ticagrelor on Fractional Flow Reserve

Fractional Flow Reserve

Greece
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Leukemia

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Lymphoma | Leukemia

United States
RemeGen Co., Ltd.

Recruiting

Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer

Breast Cancer

China
Emory University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Oral Anti Diabetic Agents in the Hospital

Diabetes Mellitus

United States
GlaxoSmithKline

Recruiting

Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM5)

Multiple Myeloma

United States, Australia, France, Japan, Netherlands, Poland, Spain, Sweden, Greece, Canada, Korea, Republic of, Germany, Brazil, Israel, Mexico, Norway, Russian Federation
Lydia Kwak
Swedish Council for Working Life and Social Research

Completed

Exploring Effectiveness and Mechanism of Change of an Implementation Strategy on Guideline Implementation in Schools

Stress | Mental Disorder

Sweden
National Cancer Institute, Naples
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer (MITO16MANGO2b)

Recurrent Ovarian Cancer

France, Italy, Switzerland, Monaco, Greece
European Organisation for Research and Treatment...

Completed

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

Ovarian Neoplasms

Spain, Switzerland, Netherlands, United Kingdom, France
M.D. Anderson Cancer Center

Completed

Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies

Advanced Cancer

United States
National Cancer Institute (NCI)

Terminated

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004

Colorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Colorectal Adenocarcinoma

United States
NSABP Foundation Inc
Genentech, Inc.; International Drug Development Institute

Completed

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Breast Cancer

United States, Canada

Search clinical trials for: Delayed leg training

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations